Form 4 for ASMB ASSEMBLY BIOSCIENCES, INC.
Accepted 2024-03-29 00:00:00 ET · period of report 2024-03-27 · accession 0000950170-24-038630 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-29 | 2024-03-27 | ASMB | Okazaki Jason A | CEO, Pres, Dir | S - Sale | $12.87 | -392 | 14.2K | -3% | -$5,045 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-27 | S | D | 392 | $12.87 | 14,180 | D | — | — | (F2) Reflects equitable adjustment of the number of shares of common stock beneficially owned by the reporting person as a result of a 1-for-12 reverse stock split of the Issuer's common stock effected February 9, 2024, which is exempt from reporting pursuant to Rule 16a-9. |